Latest Insider Transactions at Ranpak Holdings Corp. (PACK)
This section provides a real-time view of insider transactions for Ranpak Holdings Corp. (PACK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ranpak Holdings Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ranpak Holdings Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,971
+1.17%
|
$17,826
$6.31 P/Share
|
Oct 01
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,971
+0.59%
|
$17,826
$6.31 P/Share
|
Oct 01
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,971
+2.98%
|
$17,826
$6.31 P/Share
|
Oct 01
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,971
+1.33%
|
$17,826
$6.31 P/Share
|
Jul 01
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+0.61%
|
$18,528
$6.07 P/Share
|
Jul 01
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+1.4%
|
$18,528
$6.07 P/Share
|
Jul 01
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+3.19%
|
$18,528
$6.07 P/Share
|
Jul 01
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+1.23%
|
$18,528
$6.07 P/Share
|
May 30
2024
|
Michael Anthony Jones Director |
SELL
Open market or private sale
|
Direct |
15,625
-6.78%
|
$93,750
$6.41 P/Share
|
May 23
2024
|
Thomas F. Corley Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+16.89%
|
-
|
May 23
2024
|
Robert C King Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+9.86%
|
-
|
May 23
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+14.69%
|
-
|
May 23
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+6.35%
|
-
|
May 23
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+3.05%
|
-
|
May 23
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+6.01%
|
-
|
May 23
2024
|
Kurt Zumwalt Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+14.63%
|
-
|
Apr 01
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+3.04%
|
$16,506
$7.95 P/Share
|
Apr 01
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+1.09%
|
$16,506
$7.95 P/Share
|
Apr 01
2024
|
Kurt Zumwalt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+3.03%
|
$16,506
$7.95 P/Share
|
Apr 01
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+0.49%
|
$16,506
$7.95 P/Share
|
Apr 01
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+1.02%
|
$16,506
$7.95 P/Share
|
Mar 19
2024
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
5,896
-3.31%
|
$41,272
$7.35 P/Share
|
Mar 19
2024
|
William Drew Chief Financial Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,340
-0.85%
|
$30,380
$7.35 P/Share
|
Mar 19
2024
|
Omar Asali CEO and Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,924
-0.41%
|
$76,468
$7.35 P/Share
|
Mar 19
2024
|
Mark A. Siebert MD, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
3,946
-4.3%
|
$27,622
$7.35 P/Share
|
Mar 19
2024
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,480
-1.92%
|
$17,360
$7.35 P/Share
|
Mar 14
2024
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,730
+12.13%
|
-
|
Mar 14
2024
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
29,484
+24.3%
|
-
|
Mar 14
2024
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
35,725
+16.71%
|
-
|
Mar 14
2024
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,862
+12.13%
|
-
|
Mar 14
2024
|
Omar Asali CEO and Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
93,777
+3.42%
|
-
|
Mar 14
2024
|
William Drew Chief Financial Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
31,258
+5.75%
|
-
|
Mar 06
2024
|
William Drew Chief Financial Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,859
-1.0%
|
$19,436
$4.55 P/Share
|
Mar 06
2024
|
Omar Asali CEO and Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
14,053
-0.55%
|
$56,212
$4.55 P/Share
|
Mar 06
2024
|
Michael S. Gliedman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,777
-2.43%
|
$11,108
$4.55 P/Share
|
Mar 06
2024
|
Eric Laurensse Managing Director, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
6,600
-4.43%
|
$26,400
$4.55 P/Share
|
Mar 06
2024
|
Michael Anthony Jones Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,402
-6.35%
|
$57,608
$4.55 P/Share
|
Mar 05
2024
|
Antonio Grassotti Managing Director, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,343
+13.58%
|
-
|
Mar 05
2024
|
Mark A. Siebert MD, North America |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+24.73%
|
-
|
Mar 05
2024
|
William Drew Chief Financial Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
30,675
+5.94%
|
-
|
Mar 05
2024
|
Omar Asali CEO and Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
92,026
+3.46%
|
-
|
Mar 05
2024
|
Michael S. Gliedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,528
+13.29%
|
-
|
Mar 05
2024
|
Eric Laurensse Managing Director, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
35,058
+19.05%
|
-
|
Jan 02
2024
|
Michael Anthony Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.4%
|
$16,110
$5.43 P/Share
|
Jan 02
2024
|
K. El Pamela Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+4.24%
|
$16,110
$5.43 P/Share
|
Jan 02
2024
|
Kurt Zumwalt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+4.22%
|
$16,110
$5.43 P/Share
|
Jan 02
2024
|
Alicia M. Tranen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.57%
|
$16,110
$5.43 P/Share
|
Jan 02
2024
|
Salil Seshadri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+0.67%
|
$16,110
$5.43 P/Share
|
Dec 13
2023
|
Alicia M. Tranen Director |
BUY
Bona fide gift
|
Indirect |
146,484
+49.18%
|
-
|
Dec 13
2023
|
Alicia M. Tranen Director |
SELL
Bona fide gift
|
Indirect |
170,560
-54.35%
|
-
|